Stay updated on Clinical Trial: Reboxetine in Narcolepsy & Cataplexy

Sign up to get notified when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.
Latest website image capture
Clouds background image

Latest updates to the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page

  1. Check
    7 days ago
    Change Detected
    Summary
    Footer revision updated from v3.5.0 to v3.5.2. This appears to be a technical update and does not affect study details or primary page functionality.
    Difference
    0.1%
    Check dated 2026-04-16T11:15:31.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Added revision: v3.5.0 and removed revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T19:22:05.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page shows an update from Revision: v3.4.2 to Revision: v3.4.3. This appears to be a minor update with no visible changes to study details or navigation.
    Difference
    0.1%
    Check dated 2026-03-11T17:14:46.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Narcolepsy is now listed as a topic and a Genetic and Rare Diseases Information Center resource was added under resources, with the page updated to v3.4.2. The funding-status notice and the previous v3.4.1 revision note were removed.
    Difference
    0.6%
    Check dated 2026-02-11T02:46:22.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Added a government funding lapse notice informing users that information may not be up to date and transactions may not be processed. Updated the site revision from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T00:22:08.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added a glossary display, updated QC metadata labels (Last Update Submitted that Met QC Criteria), added No FEAR Act Data, and introduced Revision: v3.4.0. Removed the older QC wording (Last Update Submitted that met QC Criteria), removed No FEAR Act data, and removed the v3.3.4 revision label.
    Difference
    0.2%
    Check dated 2026-01-27T23:21:07.000Z thumbnail image

Stay in the know with updates to Clinical Trial: Reboxetine in Narcolepsy & Cataplexy

Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Reboxetine in Narcolepsy & Cataplexy page.